Continuing Pharmacy EducationNCT01339364
Impact of Three Continuing Education Meetings for Community Pharmacists on Weight Management
A study testing Didactic Lecture, Interactive Lecture and Lecture plus Small Group Education in people with Continuing Pharmacy Education and Obesity, run by Tehran University of Medical Sciences at 1 site in Iran.
Trial summary
This study is a three-arm randomized controlled trial to evaluate the effects of 1-day continuing educational meetings for community pharmacists with three distinct educational methods: 1) Didactic lecture 2) Didactic lecture plus case discussion in a large group 3) Didactic lecture plus small group education with… Read more about this study
- Who is it for?
- Ages 25 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Continuing Pharmacy Education, Obesity
- What is being tested?
- Didactic Lecture, Interactive Lecture and Lecture plus Small Group Education
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 180 participants
- Where
- 1 siteIran
- Study dates
- Jan 2011to Jun 2011
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 25 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Community Pharmacist
Who cannot join
- Less than four hours of daily work in community pharmacy
Trial locations and contacts
1 site in 1 country.
Iran1 site
Faculty of Pharmacy-Tehran University of Medical Sciences
Tehran, Tehran Province
About this study
Official title: Evaluation of Three 1-day Educational Intervention to Promote Knowledge and Attitude of Community Pharmacists About Evidence-based Weight Management
This study is a three-arm randomized controlled trial to evaluate the effects of 1-day continuing educational meetings for community pharmacists with three distinct educational methods: 1) Didactic lecture 2) Didactic lecture plus case discussion in a large group 3) Didactic lecture plus small group education with simulated patient
Knowledge and attitude of the participants would be measured as the study outcome in three periods: pre-education, post-education and 1 month after the meetings.
Read the detailed description
The study is designed as an Instructor blinded-Randomized Controlled Trial.
An educational need assessment is undergone prior to educational content preparation by interviewing 5 community pharmacists. After educational content preparation by instructors, the outcome assessment tool (knowledge, attitude questionnaire) would be designed by a distinct investigator. Closed and Open-ended questions are included to investigate different levels of Bloom's taxonomy.
The questionnaire would be validated by specialists other than the instructors and it will piloted to investigate the reliability( Cronbach's Alfa > 0.7).
Community pharmacists of Tehran,Capital city of Iran, would be invited to participate in the study. The participants would be randomly assigned to 3 groups by random number table. Each group receives the same education content with a different method:
- Didactic lecture
- Didactic lecture plus case discussion in a large group
- Didactic lecture plus small group education with simulated patient(SP). Interviewing with SP is conducted by small group facilitators with Brain Storming Technic.
Each participant receives a compact disk which includes the educational material and he/she would be able to contact the instructors by phone or e-mail during the follow-up period. (Reinforcement Phase)
- Conditions
- Continuing Pharmacy Education, Obesity
- Being tested
- Didactic Lecture, Interactive Lecture, Lecture plus Small Group Education
- Medical subject headings
- Obesity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Didactic LectureOther
2 sessions of didactic lecture with PowerPoint presentations each delivered by a special lecturer. whole education period lasts 3 hours.
Interactive LectureOther
2 sessions of brief interactive lectures followed by case discussion sections.
Lecture plus Small Group EducationOther
A 1.5 hours session of didactic lecture followed by a session of small group education with 3 simulated patients.
| Study group | Role | What they receive |
|---|---|---|
| Didactic Lecture | Active comparator | Not described Receives: Other: Didactic Lecture |
| Lecture plus Case Disscussion | Experimental | Not described Receives: Other: Interactive Lecture |
| Lecture plus Small Group Education | Experimental | Not described Receives: Other: Lecture plus Small Group Education |
What is being measured
The primary outcome is the main question the study is designed to answer.
Knowledge Grade Points and Attitudes(Phase 1)
Obtained through a validated knowledge and attitude questionnaire.
Measured: One day
Knowledge Grade Points and Attitudes(Phase 2)
Obtained through a validated knowledge and attitude questionnaire.
Measured: One month(average of 4 weeks after the day of training)
Secondary outcomes (1)
Satisfaction of Participants
Obtained by a Satisfaction Evaluation Questionnaire.
Measured: One day
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Apr 2011 (estimated)
- Study startJan 2011
- Primary completionMay 2011
- Study completionJun 2011
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Continuing Pharmacy EducationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Care provider
- Enrolment
- 180 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Tehran University of Medical Sciences
- Sponsor type
- University, hospital or other
- Investigators
- Kheirollah Gholami, M.Sc, PharmD, Study chair, Tehran University of Medical SciencesArash Rashidian, MD, PhD, Principal investigator, Tehran University of Medical SciencesMohammadreza Javadi, PharmD, BCPS, Principal investigator, Tehran University of Medical SciencesAmir Sarayani, PharmD, MPH, Principal investigator, Tehran University of Medical Sciences
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01339364
- Sponsor's protocol ID
- 240/4402
- Status last verified
- Jul 2011
- First submitted
- 15 Apr 2011
- Last updated
- 26 Jul 2011
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 26 Jul 2011. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of Three 1-day Educational Intervention to Promote Knowledge and Attitude of Community Pharmacists About Evidence-based Weight Management
- ClinicalTrials.gov ID
- NCT01339364
- Acronym / sponsor ID
- 240/4402
- Conditions
- Continuing Pharmacy Education, Obesity
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 180 participants (estimated)
- Lead sponsor
- Tehran University of Medical SciencesUniversity, hospital or other
- Study start
- Jan 2011
- Primary completion
- May 2011 (actual)
- Study completion
- Jun 2011 (actual)
- First posted
- 20 Apr 2011 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study is a three-arm randomized controlled trial to evaluate the effects of 1-day continuing educational meetings for community pharmacists with three distinct educational methods: 1) Didactic lecture 2) Didactic lecture plus case discussion in a large group 3) Didactic lecture plus small group education with simulated patient
Knowledge and attitude of the participants would be measured as the study outcome in three periods: pre-education, post-education and 1 month after the meetings.
Detailed description
The study is designed as an Instructor blinded-Randomized Controlled Trial.
An educational need assessment is undergone prior to educational content preparation by interviewing 5 community pharmacists. After educational content preparation by instructors, the outcome assessment tool (knowledge, attitude questionnaire) would be designed by a distinct investigator. Closed and Open-ended questions are included to investigate different levels of Bloom's taxonomy.
The questionnaire would be validated by specialists other than the instructors and it will piloted to investigate the reliability( Cronbach's Alfa > 0.7).
Community pharmacists of Tehran,Capital city of Iran, would be invited to participate in the study. The participants would be randomly assigned to 3 groups by random number table. Each group receives the same education content with a different method:
- Didactic lecture
- Didactic lecture plus case discussion in a large group
- Didactic lecture plus small group education with simulated patient(SP). Interviewing with SP is conducted by small group facilitators with Brain Storming Technic.
Each participant receives a compact disk which includes the educational material and he/she would be able to contact the instructors by phone or e-mail during the follow-up period. (Reinforcement Phase)
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (care provider)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Didactic Lecture | Active comparator | Other: Didactic Lecture |
| Lecture plus Case Disscussion | Experimental | Other: Interactive Lecture |
| Lecture plus Small Group Education | Experimental | Other: Lecture plus Small Group Education |
Who may qualify
- Ages
- 25 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Community Pharmacist
Key exclusion criteria (1 listed)
- Less than four hours of daily work in community pharmacy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Didactic Lecture2 sessions of didactic lecture with PowerPoint presentations each delivered by a special lecturer. whole education period lasts 3 hours. | Other | Didactic Lecture |
| Interactive Lecture2 sessions of brief interactive lectures followed by case discussion sections. | Other | Lecture plus Case Disscussion |
| Lecture plus Small Group EducationA 1.5 hours session of didactic lecture followed by a session of small group education with 3 simulated patients. | Other | Lecture plus Small Group Education |
Primary outcome
Knowledge Grade Points and Attitudes(Phase 1)
Time frame: One day
Obtained through a validated knowledge and attitude questionnaire.
Knowledge Grade Points and Attitudes(Phase 2)
Time frame: One month(average of 4 weeks after the day of training)
Obtained through a validated knowledge and attitude questionnaire.
1 secondary outcome
Satisfaction of Participants
Time frame: One day
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Jul 2011.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Kheirollah Gholami, M.Sc, PharmD study chair
Tehran University of Medical Sciences
Arash Rashidian, MD, PhD principal investigator
Tehran University of Medical Sciences
Mohammadreza Javadi, PharmD, BCPS principal investigator
Tehran University of Medical Sciences
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Didactic Lecture, Interactive Lecture and Lecture plus Small Group Education in people with Continuing Pharmacy Education and Obesity, run by Tehran University of Medical Sciences at 1 site in Iran.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 26 Jul 2011. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Iran. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Knowledge Grade Points and Attitudes(Phase 1) (time frame: One day). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jul 2011.